Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(17%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_3
1
17%
Ph phase_1
1
17%
Ph phase_2
1
17%
Ph phase_4
1
17%
Ph not_applicable
2
33%

Phase Distribution

1

Early Stage

1

Mid Stage

2

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
1(16.7%)
Phase 3Large-scale testing
1(16.7%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
2(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

66.7%

2 of 3 finished

Non-Completion Rate

33.3%

1 ended early

Currently Active

1

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(1)
Other(2)

Detailed Status

Completed2
unknown2
Withdrawn1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
1
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (16.7%)
Phase 21 (16.7%)
Phase 31 (16.7%)
Phase 41 (16.7%)
N/A2 (33.3%)

Trials by Status

withdrawn117%
completed233%
recruiting117%
unknown233%

Recent Activity

1 active trials
Showing 5 of 6
recruitingphase_2

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

NCT07370519
unknownnot_applicable

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

NCT06218394
unknownnot_applicable

Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

NCT06218498
withdrawnphase_4

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

NCT02483195
completedphase_1

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

NCT02280603
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT07370519Phase 2

Topical Application of Lactobacillus Reuteri for Androgenetic Alopecia

Recruiting
NCT06218394Not Applicable

Comparison of Microneedling vs. Autologous Concentrated Growth Factor for the Treatment of Female Androgenetic Alopecia

Unknown
NCT06218498Not Applicable

Comparison of an Non-ablative Fractional 1565nm vs. an Ablative 2940-nm Fractional Er Laser for the Treatment of Androgenetic Alopecia

Unknown
NCT02483195Phase 4

The Use of 5mg Finasteride Versus 200mg Spironolactone and Topical 5% Minoxidil in Treating Postmenopausal Female Androgenetic Alopecia

Withdrawn
NCT02280603Phase 1

Clinical Trial to Explore the Efficacy and Safety of DA-4001 After Topical Application

Completed
NCT01145625Phase 3

Clinical Trial in Females With Female Pattern Hair Loss

Completed

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6